Anzeige
Mehr »
Login
Mittwoch, 15.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Das 13-Millionen-Unternehmen mit einer Monster-Entdeckung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 869353 | ISIN: US4932671088 | Ticker-Symbol: KEY
Tradegate
14.01.25
18:25 Uhr
16,740 Euro
-0,234
-1,38 %
1-Jahres-Chart
KEYCORP Chart 1 Jahr
5-Tage-Chart
KEYCORP 5-Tage-Chart
RealtimeGeldBriefZeit
16,76017,07208:53
16,74817,08408:53
ACCESSWIRE
250 Leser
Artikel bewerten:
(1)

$250,000 Investment by the KeyBank Foundation to Support United Way of Central New York's Thrive at Work Financial Education & Resource Program

Finanznachrichten News

NORTHAMPTON, MA / ACCESSWIRE / September 12, 2024 / KeyBank
New, innovative initiative is meant to help individuals who are employed but face challenges meeting basic financial needs due to limited access to financial resources and support

The KeyBank Foundation is investing $250,000 in the United Way of Central New York's Thrive at Work Program. This new, innovative initiative is meant to help individuals who are employed but face challenges meeting basic financial needs due to limited access to financial resources and support.

Thrive at Work will focus on employees in entry-level or lower-income positions at small- to mid-sized companies in Central New York. Following a six-to-nine month build phase, the program will offer financial education, low-interest loans, one-on-one financial coaching, and free tax preparation services, empowering employees to better manage their finances.

"We applaud the United Way of Central New York for their innovative approach to helping working people in our community overcome challenges and access resources and support that can help them grow financially," said Stephen Fournier, KeyBank Central New York Market President. "KeyBank's purpose is to help the communities we serve thrive. Thrive at Work is a program we are proud to help build and support. We look forward to seeing the ways this will help people and communities in Central New York grow."

"KeyBank Foundation's investment makes it possible for us to launch this critical program to assist hardworking families who are striving yet struggling to get by," said Nancy Kern Eaton, United Way of Central New York President. "Far too many people in our community are one financial emergency away from a downward spiral. Helping people manage financial and other crises will keep people focused on work while they continue to move forward in efforts to achieve their dreams and build a more stable future."

Specifically, Thrive at Work will provide financial stability and resilience for Asset Limited, Income Constrained, Employed (ALICE) individuals in Onondaga County, who represent 25% of the county's households. The United Way of Central New York anticipates participants will show significant improvements in financial literacy, credit scores, debt reduction and savings. Additionally, it expects enhanced workplace engagement, reduced absenteeism due to financial stress, and increased job satisfaction.

"We are excited about the resources and education Thrive at Work will bring to our community, said Tamika Otis, KeyBank Corporate Responsibility Officer in Central New York. "This initiative will help working people in our region access the tools they need to help them reduce debt, save money and build wealth."

Since 2017, KeyBank has made more than $700 million in investments in Syracuse and Central New York, supporting affordable housing and community development projects; small business and home lending to low-to-moderate income individuals and communities, and transformative philanthropy.

ABOUT KEYCORP

KeyCorp's roots trace back nearly 200 years to Albany, New York. Headquartered in Cleveland, Ohio, Key is one of the nation's largest bank-based financial services companies, with assets of approximately $187 billion at June 30, 2024. Key provides deposit, lending, cash management, and investment services to individuals and businesses in 15 states under the name KeyBank National Association through a network of approximately 1,000 branches and approximately 1,200 ATMs. Key also provides a broad range of sophisticated corporate and investment banking products, such as merger and acquisition advice, public and private debt and equity, syndications and derivatives to middle market companies in selected industries throughout the United States under the KeyBanc Capital Markets trade name. For more information, visit? https://www.key.com/. KeyBank Member FDIC.

ABOUT UNITED WAY OF CENTRAL NEW YORK

United Way of Central New York, Inc., is an innovative and collaborative local nonprofit organization that drives solutions to the most pressing human service community needs of Central New York. Through our advocacy and relevant leadership, we provide options for impactful giving and we fund programs and initiatives that help create a thriving community. We are guided by our values of compassion, empowerment, collaboration, leadership, and inclusion. For more information, visit www.UnitedWay-CNY.org United, we do more.

View additional multimedia and more ESG storytelling from KeyBank on 3blmedia.com.

Contact Info:
Spokesperson: KeyBank
Website: https://www.3blmedia.com/profiles/keybank
Email: info@3blmedia.com

SOURCE: KeyBank



View the original press release on accesswire.com

© 2024 ACCESSWIRE
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.